Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2025-01-03T17:43:35.601Z Has data issue: false hasContentIssue false
  • English
  • Français

A Comparison Between Prochlorperazine and Chlorpromazine in Mental Deficiency

Published online by Cambridge University Press:  08 February 2018

H. P. Robb
H. P. Robb*
Affiliation:
Aycliffe Hospital, Heighington, Darlington, County Durham; Ladysbridge Certified Institution, Banff, Scotland
Get access Rights & Permissions [Opens in a new window]

Extract

Tranquillizing drugs that have been used in mental deficiency include reserpine, chlorpromazine, promazine, mepazine, hydroxyzine and prochlorperazine.

Esen and Durling (1) thought that the tranquillizing drugs in general were a useful preliminary to psychotherapy. However, the response to individual drugs has been variable.

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 445 , October 1960 , pp. 1413 - 1416
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Esen, F. M., and Durling, D., Arch. Pediat., 1956, 73, 168.Google Scholar
2 Johnston, A. H., and Martin, C. H., “The clinical use of reserpine and chlorpromazine in the care of the mentally deficient”, Amer. J. Ment. Defic., 1957, 62, 292.Google Scholar
3 Horenstein, S., “Reserpine and chlorpromazine in hyperactive mental defectives”, ibid., 1957, 61, 525.Google Scholar
4 Sprogis, G. R., Lezdine, V., White, S. D., Ming, C., Laming, M., Drake, M. E., and Wyckoff, G., “Comparative study of thorazine and Serpasil in the mental defective”, ibid., 1957, 61, 737.Google Scholar
5 Tarjan, G., Lowery, V. E., and Wright, S. W., “Use of chlorpromazine in the hundred and seventy-eight mentally deficient patients”, A.M.A. Dis. Childh., 1957, 94, 294.Google Scholar
6 Adamson, W. C., “Use of tranquillisers for mentally deficient patients”, ibid., 1958, 96, 159.Google Scholar
7 Robb, H. P., “The use of chlorpromazine in a mental deficiency institution”, J. Ment. Sci., 1959, 105, 1029.CrossRefGoogle Scholar
8 Blair, H. B., and Harold, W., “Efficacy of chlorpromazine in hyperactive mentally retarded children”, Arch. Neurol. and Psych., 1955, 74, 363.Google Scholar
9 Gillie, Anne K., “The use of Pacatal in low-grade mental defectives”, J. Ment. Sci., 1957, 103, 431.CrossRefGoogle Scholar
10 Bergin, J. T. F., and Bergin, Mary M., “The use of Sparine in low-grade mental defectives”, J. Irish med. Ass., 1958, 52, 247.Google Scholar
11 Craft, M., “Tranquillisers in mental deficiency: hydroxyzine”, J. Ment. Sci., 1957, 103, 433.CrossRefGoogle Scholar
12 Pilkington, T. L., “Prochlorperazine (Stemetil) in mental deficiency”, ibid., 1959, 105, 215.Google Scholar
13 Kline, V. S., Barsa, J. A., Bruckman, N. S., and Saunders, J. C., “The use of prochlorperazine (Compazine) in a variety of psychiatric conditions”, Psychiat. Res. Reports, 1958, No. 9, 5.Google Scholar
14 Freyhan, F. A., “The neuroleptic action and effectiveness of prochlorperazine in psychiatric disorders”, ibid., 1958, No. 9, 32.Google Scholar
15 Achaintre, A., Balvet, P., Beaujard, M., Berthier, C., Broussolle, P., Lambert, P., Perrin, J., Requet, A., and Revol, L., “New phenothiazine derivatives in the treatment of schizophrenia”, Communication to the International Congress, Zurich, September, 1957.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.